# Release notes for aml_v1.3

Added concepts:<br>
[Subject Characteristics].[STUDY_ID].[AMLBFM2004 Interim]<br>
[Subject Characteristics].[STUDY_ID].[AMLBFM2019]<br>
[Subject Characteristics].[STUDY_ID].[AMLBFM2020]<br>
[Subject Characteristics].[STUDY_ID].[AMLBFM98 Interim 2003]<br>
[Subject Characteristics].[STUDY_ID].[APL]<br>
[Subject Characteristics].[STUDY_ID].[NOPHOAML1993]<br>
[Molecular Analysis].[MOLECULAR_ABNORMALITY].[ETV6-MN1 Fusion]<br>
[Molecular Analysis].[MOLECULAR_ABNORMALITY].[FLT3 D835N Pathogenic Variant]<br>
[Molecular Analysis].[MOLECULAR_ABNORMALITY].[MLL-MLLT10(AF10) Fusion]<br>
[Molecular Analysis].[MOLECULAR_ABNORMALITY].[MLL-MLLT3 Fusion]<br>
[Molecular Analysis].[MOLECULAR_ABNORMALITY].[PML-RARA Fusion]<br>
[Molecular Analysis].[MOLECULAR_ABNORMALITY].[Other]<br>
[Molecular Analysis].[MOLECULAR_ABNORMALITY].[Not Reported]<br>
[Disease Characteristics].[WHO_AML].[WHO >> Version 5 >> AML with KMT2A Rearrangement]<br>

Removed concepts:<br>
[Disease Characteristics].[FAB_TYPE].[Unknown]<br>

Modified concepts:<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> APL with PML-RARA]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[APL with PML-RARA]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with t(6;9)(p23;q34.1);DEK-NUP214]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML with t(6;9)(p23;q34.1);DEK-NUP214]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML (megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML (megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Provisional Entity: AML with BCR-ABL1]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Provisional Entity: AML with BCR-ABL1]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with Mutated NPM1]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML with Mutated NPM1]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with Biallelic Mutations of CEBPA]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML with Biallelic Mutations of CEBPA]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Provisional Entity: AML with Mutated RUNX1]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Provisional Entity: AML with Mutated RUNX1]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with Myelodysplasia-related Changes]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML with Myelodysplasia-related Changes]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Therapy-Related Myeloid Neoplasms]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Therapy-Related Myeloid Neoplasms]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with Minimal Differentiation]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML with Minimal Differentiation]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML without Maturation]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML without Maturation]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with Maturation]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[AML with Maturation]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Acute Myelomonocytic Leukemia]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Acute Myelomonocytic Leukemia]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Acute Monoblastic/Monocytic Leukemia]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Acute Monoblastic/Monocytic Leukemia]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Pure Erythroid Leukemia]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Pure Erythroid Leukemia]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Acute Megakaryoblastic Leukemia]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Acute Megakaryoblastic Leukemia]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Acute Basophilic Leukemia]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Acute Basophilic Leukemia]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Acute Panmyelosis with Myelofibrosis]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Acute Panmyelosis with Myelofibrosis]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Myeloid Sarcoma]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Myeloid Sarcoma]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Myeloid Proliferations Related to Down Syndrome]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Myeloid Proliferations Related to Down Syndrome]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Transient Abnormal Myelopoiesis (TAM)]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Transient Abnormal Myelopoiesis (TAM)]<br>
[aml_v1.3].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Myeloid Leukemia Associated with Down Syndrome]	skos:exactMatch	[aml_v1.2].[Disease Characteristics].[WHO_AML].[Myeloid Leukemia Associated with Down Syndrome]
